Biosimilar drugs: Current status

Biosimilar drugs: Current status

Item
http://www.wikidata.org/entity/Q27004314
Recent Advances in Application of Pharmacogenomics for BiotherapeuticsUpdates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm MeetingUsing simple models to describe the kinetics of growth, glucose consumption, and monoclonal antibody formation in naive and infliximab producer CHO cells.Improving Access to Cancer Treatments: The Role of Biosimilars.Protein biomarkers for subtyping breast cancer and implications for future research.The road from development to approval: evaluating the body of evidence to confirm biosimilarity.Parallel experimental design and multivariate analysis provides efficient screening of cell culture media supplements to improve biosimilar product quality.Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations.
P2860

Biosimilar drugs: Current status

Item
http://www.wikidata.org/entity/Q27004314
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Biosimilar drugs: Current status
@ast
Biosimilar drugs: Current status
@en
Biosimilar drugs: Current status
@nl
type
label
Biosimilar drugs: Current status
@ast
Biosimilar drugs: Current status
@en
Biosimilar drugs: Current status
@nl
prefLabel
Biosimilar drugs: Current status
@ast
Biosimilar drugs: Current status
@en
Biosimilar drugs: Current status
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Biosimilar drugs: Current status
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932